[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Arrowhead Research Corporation (ARWR)
Arrowhead Pharmaceuticals (ARWR) reassures investors about its deal with Sarepta Therapeutics (SRPT) despite recent setbacks. The company expects near-term payments and is actively addressing concerns amidst market volatility.
About Arrowhead Research Corporation
Arrowhead Research Corporation (ARWR) is a biopharmaceutical company focused on RNA interference (RNAi) based medicines.
Arrowhead Research Corporation uses the ticker $ARWR for trading. Listed in the Stocks and category within the Healthcare sectors.
Insights #
- Arrowhead Research Corporation (ARWR) trading volume is up XXXXXX% from the previous week.
- Arrowhead Research Corporation (ARWR) social dominance is up XXXXX% from the previous week.
- Arrowhead Research Corporation (ARWR) creators is up XXXXXX% from the previous month.
- Arrowhead Research Corporation (ARWR) engagements is up XXXXX% from the previous month.
- Arrowhead Research Corporation (ARWR) mentions is up XXX% from the previous month.
- Arrowhead Research Corporation (ARWR) posts created is up XXXXXX% from the previous month.
Price: $XXXXX #
Price 24-Hour Chart Data
The current price decrease of -XXXX% is likely influenced by overall market volatility, which seems to be overriding positive sentiment from analyst ratings and Phase X enrollment. The negative price action is also influenced by the top social posts mentioning ARWR as a loser stock.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| XXXX% | -XXXXX% | XXXX% |
1-Year High: $XXXXX on 2024-07-25
1-Year Low: $XX on 2025-04-08
AltRank: XXX #
AltRank 24-Hour Chart Data
Arrowhead Research Corporation (ARWR) is currently AltRank #178 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXX -XXX
1 Month: XXX -XX
6 Months: XXX -XX
1 Year: XXX -XXX
1-Year High: XXXXX on 2025-05-30
1-Year Low: XX on 2024-11-27
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -XX
1 Month: XX +20
6 Months: XX +23
1 Year: XX +21
1-Year High: XX on 2024-09-18
1-Year Low: XX on 2024-08-12
Engagements: XXXXXX #
Engagements 24-Hour Chart Data
Current Value: XXXXXX
Daily Average: XXXXXX
1 Week: XXXXXXX +28%
1 Month: XXXXXXX +39%
6 Months: XXXXXXXXX -XX%
1 Year: XXXXXXXXX +20%
1-Year High: XXXXXXX on 2024-12-13
1-Year Low: XXX on 2025-04-27
| Social Network | X | |
|---|---|---|
| Engagements | XXXXXX | X |
Mentions: XXX #
Mentions 24-Hour Chart Data
Current Value: XXX
Daily Average: XXX
1 Week: XXX +44%
1 Month: XXXXX +193%
6 Months: XXXXX -XX%
1 Year: XXXXX +205%
1-Year High: XXX on 2024-12-03
1-Year Low: XX on 2024-08-29
| Social Network | X | |
|---|---|---|
| Mentions | XXX | X |
Creators: XX #
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning Arrowhead Research Corporation (ARWR) in the last XX hours which is down XX% from XXX in the previous XX hours
Daily Average: XX
1 Week: XXX +27%
1 Month: XXX +349%
6 Months: XXXXX -XXXX%
1 Year: XXXXX +199%
1-Year High: XXX on 2024-11-28
1-Year Low: XX on 2024-09-16
The most influential creators that mention Arrowhead Research Corporation in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BioStocks | X | XXXXXX | X | XXXXX |
| @Tickeron | X | XXXXXX | X | XXXXX |
| @BikeRieder | X | XXXXX | X | XXXXX |
Sentiment: XX% #
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -X%
1 Month: XX% +5%
6 Months: XX% -X%
1 Year: XX% -X%
1-Year High: XXX% on 2024-07-29
1-Year Low: XX% on 2025-03-21
Most Supportive Themes
- Pipeline and Drug Development: (10%) Positive sentiment regarding Arrowhead's pipeline advancements and new drug developments.
- Analyst Ratings and Platform Advantages: (84%) Positive sentiment from analysts' positive price targets and the potential of Arrowhead's TRiM platform.
Most Critical Themes
- Valuation Concerns & Short Squeeze: (2%) Concerns about market manipulation and perceived undervaluation.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXXXXX | XX% | XXX | X% |
| X | X% | X | X% | X | X% | |
| Total | XXXXX | XX% | XXXXXX | XX% | XXX | X% |
Social Dominance: XXXXX% #
Social Dominance 24-Hour Chart Data
Current Value: XXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% +0.0047%
1 Month: XXXXX% -XXXXXX%
6 Months: XXXXX% -XXXXX%
1 Year: XXXXX% +0.0048%
1-Year High: XXXXX% on 2024-12-03
1-Year Low: XXXXX% on 2024-07-31
Market Dominance: XXXXXXX% #
Market Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2024-08-05
1-Year Low: XXXXXXX% on 2025-07-24
Market Cap: $XXXXXXXXXXXXX #
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX -$16%
1 Month: $XXXXXXXXXXXXX +$0.06%
6 Months: $XXXXXXXXXXXXX -$14%
1 Year: $XXXXXXXXXXXXX -$39%
1-Year High: $XXXXXXXXXXXXX on 2024-07-25
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08
Top assets mentioned In the posts about Arrowhead Research Corporation in the last XX hours
Sarepta Therapeutics, Inc. (SRPT) Sarepta Therapeutics, Inc. (SRPT) Alnylam Pharmaceuticals, Inc. (ALNY) Regeneron Pharmaceuticals Inc (REGN) Bitcoin Incognito (XBI) Eli Lilly and Company (LLY) Akropolis (AKRO) SuperRare (RARE) Ionis Pharmaceuticals, Inc. Common Stock (IONS)
Top topics mentioned In the posts about Arrowhead Research Corporation in the last XX hours
$srpt, mrna, $bcrx, $adpt, stocks healthcare, $nktr, sarepta therapeutics inc, arrowhead, stocks, $alny, nvda, $regn, rna, $xbi, $drna, $lly, btc eth, cvx, pltr, qqq, spx, coins ai, $akro, $rgnx, amgn, $qure, mstr, googl, $allo, gainers, $rare, $ions, investment, msft, vale, iren, clov, vrtx, $wve, $cmps, sarepta therapeutics, stx, $dyn, $rna, $qntm, eli lilly, moh, $moh, qbts, hims, telo, dtc, fubo, mor, cort, $entb, $auph, $amgn, alnylam pharmaceuticals inc, $ibb, amzn, clsk, trn, $lyel, $fsm, hood, $nvs, $brkr, psix, glxy, $sgmo, $hnsa, onds, oscr, $prme, $mor, pfe, $tnxp, $btk, $crbu, ogn, $ctos, $lixt, $jdzg, $adap, $kura, $prqr, $argx, nasdaq, $veon, vir, $rklb, momentum, bgl, $300m, smci, $mcrb, op, sonn, balance sheet
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$SRPT survived longer than I expected actually. Stop blaming FDA. It's always been a controversial play / a ticking bomb. Now they need to shift the entire focus to $ARWR compounds. But not sure about the path forward here for them with that debt pile. $XBI"
@PikaCapital on X 2025-07-24 16:46:18 UTC 2755 followers, 2801 engagements
"H.C. Wainwright reiterated $KRRO Buy-$100 and said "Yesterday we hosted Korro Bio in the latest episode of our H.C. Wainwright @ Home series." $BEAM $WVE $PRQR $ARWR $IONS $ALNY H.C Wainwright added "We have three key takeaways from our discussion: (1) while DNA-editing approaches and exogenous protein therapies are alternative options to treat AATD RNA therapy is uniquely positioned as it is a highly-specific approach that harnesses the body's machinery to restore normal protein levels and address the disease in both the lung and liver; (2) KRRO-110's IV route of administration provides a"
@Quantumup1 on X 2025-07-24 12:22:13 UTC 3519 followers, 1417 engagements
"$SYM $SQM $PCT $HOOD $VSH $CVI $WFRD $MT $COIN $MRNA $STM $SRRK $ORCL $NWL $AI $RCI $ARWR $WHR $HWKN $ENTG $TX $WRD $BHC $TSLA $TS $STX $WMG $VALE $TRN $FLEX $RUM $FSLR $GDS $RDDT $STNG $SBSW $MBLY"
@linhnguyen64143 on X 2025-07-24 00:05:18 UTC XX followers, X engagements
"$RYTM $VRNA $AES $BE $NEGG $CRNX $LGND $GRFS $SRRK $WGS $CYTK $RARE $TLX $TNXP $AG $SMMT $XENE $RNA $KNSA $FUTU $KYMR $APLS $TGTX $BBIO $AGIO $AXSM $SLNO $CRSP $ASND $FSM $PCVX $LYEL $ORLA $MDGL $ARWR $ROIV"
@linhnguyen64143 on X 2025-07-24 00:04:22 UTC XX followers, X engagements